cardiac valve diseade
Conditions
Interventions
0.25% levobupivacaine at 4 ml / h using a porous catheter, continuous administration until the first day after surgery on the wound site
Sponsors
St. marianna University school of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patient scheduled to undergo catheterization using a transapical apical approach with agreement before surgery
Exclusion criteria
Exclusion criteria: Local anesthetic drug allergy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| assessment of postoperative analgesia score (NRS) | — |
Secondary
| Measure | Time frame |
|---|---|
| postoperative blood pressure, heart rate, SpO 2, time to leave, length of stay in hospital, presence of cardiovascular complications, respiratory complications With or without | — |
Countries
Japan
Contacts
Public ContactYumi Obata
St. marianna University school of Medicine Anesthesiology
Outcome results
None listed